Cryo-EM structure of active GPR65 leadXpro has just elucidated the world’s first structure of a proton-sensing GPCR target.
leadXpro Timeline
Latest updates about leadXpro
New collaboration between leadXpro and Orbion!
Membrane proteins serve as a cell’s vital link to its external environment and play crucial roles in both health and disease. Although they make up only about a quarter of the human proteome, they are the targets of more than half of all approved drugs. However, studying these proteins in the lab is challenging due […]
leadXpro and Alipheron are combining their cutting-edge technologies to bring a new level of innovation to early drug discovery.
By applying intelligent algorithms to detect new drugs in trillions of molecules By using high-tech Cryo-EM to elucidate structures of membrane bound proteins By accelerating structure-based lead discovery to address unmet medical needs
Cumulus Oncology and leadXpro Achieve Critical Milestone in GPR68 Drug Discovery Project
Edinburgh, Scotland, and Villigen, Switzerland, 13 August 2024 – Cumulus Oncology, Europe’s first oncology-focused biotech creation company, announces that, in partnership with its collaborator leadXpro (LXP), key milestones have been achieved in their protein structure driven GPR68 drug discovery project. As a result, Cumulus has licensed the small molecule compounds and associated IP created during […]
Our partners
